Ideally, in the absence of clinically manifest angiopathy it should be possible to better determine the effects of obesity, blood pressure, and disturbances in glucose and insulin metabolism/production on the brain. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.